Google+ Facebook Twitter Twitter

Aggressive prostate cancer and mutations

An international research team has singled out mutations in 11 genes that are associated with aggressive prostate cancer.

These findings come from the largest scale prostate cancer study ever exploring the exome – the key sections of the genetic code that contain the instructions to make proteins.

The scientists analysed samples from about 17,500 prostate cancer patients.

The study, led by scientists in the Centre for Genetic Epidemiology at the Keck School of Medicine of USC and USC Norris Comprehensive Cancer Centre, uncovered mutations associated with higher risk for more aggressive, deadlier prostate cancer that are not currently included on genetic test panels. The researchers also found some genes that are currently part of such panels that are not linked with risk for aggressive disease.

Corresponding author Christopher Haiman said: “It’s clear that more work needs to be done to determine which genes oncologists should focus on in testing.”

Image credit | Science-Photolibrary

Related Articles

The lesser horseshoe bat (Rhinolophus hipposideros)-Image Credit | istock-816193242

Bat swarming and immunity

Bats carry some of the deadliest zoonotic diseases that can infect both humans and animals, such as Ebola and COVID-19.

Pancreas or pancreatic cancer with organs and tumors or cancerous cells 3D rendering illustration with male bodyImage Credit | istock-1467893187

Fibroblast cells and pancreatic cancer growth

Older people may be at greater risk of developing pancreatic cancer and have poorer prognoses because of age-related changes in cells in the pancreas called fibroblasts, it is claimed.

brain tumour CREDIT_science photo library

Pores for thought

A team from Nottingham looks at intraoperative molecular diagnosis of brain tumours using nanopore sequencing.

CRISPR-Cas9 gene editing complex, illustration.Image credit - Science-Photo-Library-f0248864

Activating genes using CRISPR technology

There are over 7000 different rare genetic diseases, and often it can be a significant challenge and take a long time to receive a correct diagnosis.